Page last updated: 2024-09-02

fingolimod hydrochloride and glycolipids

fingolimod hydrochloride has been researched along with glycolipids in 7 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)
Trials
(fingolimod hydrochloride)
Recent Studies (post-2010)
(fingolimod hydrochloride)
Studies
(glycolipids)
Trials
(glycolipids)
Recent Studies (post-2010) (glycolipids)
2,7711572,06219,0621705,050

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
de Vries, HE; Dekker, N; Dijkstra, C; Kooij, G; Lopes-Pinheiro, MA; Nijland, PG; Reijerkerk, A; van Doorn, R; van het Hof, B; van Horssen, J; van van der Valk, P; Witte, ME1
Murayama, T; Nakamura, H1
Faßbender, K; Halmer, R; Walter, S1
Balk, LJ; de Vries, HE; den Hoedt, S; Eijlers, AJC; Killestein, J; Leurs, CE; Lopes Pinheiro, MA; Mulder, MT; Schoonheim, MM; Uitdehaag, BMJ; Wierts, L1
Hazarosova, R; Krastev, N; Krastev, P; Momchilova, A; Nikolova, B; Pankov, R; Pankov, S; Pinkas, A; Robev, B; Staneva, G; Vassileva, E1
Arnold, M; Baillie, R; Baloni, P; Brauner, B; Buitrago, L; Doraiswamy, PM; Ekroos, K; Funk, CC; Han, X; Hernández, AI; Hood, L; Huynh, K; Kaddurah-Daouk, R; Kastenmüller, G; Kueider-Paisley, A; Louie, G; Meikle, PJ; Moreno, H; Nho, K; Price, ND; Saykin, AJ; Suhre, K1
Abdel-Salam, MML; Ahmad, SA; Bachmann, M; Becker, KA; Carpinteiro, A; Gulbins, E; Kadow, S; Keitsch, S; Patel, SH; Soddemann, M; Szabo, I; Wilker, B; Wilson, GC; Xu, K1

Reviews

2 review(s) available for fingolimod hydrochloride and glycolipids

ArticleYear
Role of sphingolipids in arachidonic acid metabolism.
    Journal of pharmacological sciences, 2014, Volume: 124, Issue:3

    Topics: Active Transport, Cell Nucleus; Animals; Arachidonic Acid; Cells, Cultured; Ceramides; Cyclooxygenase 2; Fingolimod Hydrochloride; Golgi Apparatus; Group IV Phospholipases A2; Humans; Inflammation; Lactosylceramides; Lysophospholipids; Propylene Glycols; Sphingolipids; Sphingomyelins; Sphingosine

2014
Sphingolipids: important players in multiple sclerosis.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2014, Volume: 34, Issue:1

    Topics: Ceramides; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lysophospholipids; Multiple Sclerosis; Propylene Glycols; Sphingolipids; Sphingomyelin Phosphodiesterase; Sphingomyelins; Sphingosine

2014

Other Studies

5 other study(ies) available for fingolimod hydrochloride and glycolipids

ArticleYear
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
    Acta neuropathologica, 2012, Volume: 124, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Astrocytes; Blood-Brain Barrier; Cell Movement; Cells, Cultured; Ceramides; Endothelial Cells; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Monocytes; Multiple Sclerosis; Propylene Glycols; Sphingomyelins; Sphingosine

2012
Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis.
    Multiple sclerosis and related disorders, 2019, Volume: 28

    Topics: Adult; Biomarkers; Ceramides; Demyelinating Diseases; Female; Fingolimod Hydrochloride; Follow-Up Studies; Humans; Immunologic Factors; Longitudinal Studies; Male; Prospective Studies; Sphingomyelin Phosphodiesterase; Sphingomyelins; Treatment Outcome

2019
Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells.
    International journal of molecular sciences, 2022, Sep-17, Volume: 23, Issue:18

    Topics: A549 Cells; Adenocarcinoma of Lung; Alkaline Ceramidase; Antioxidants; Biochemical Phenomena; Ceramides; Fingolimod Hydrochloride; Humans; Lysophospholipids; Neuroprotective Agents; Polyphenols; Resveratrol; Sphingolipids; Sphingomyelin Phosphodiesterase; Sphingomyelins; Sphingosine

2022
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease.
    Communications biology, 2022, 10-08, Volume: 5, Issue:1

    Topics: Alzheimer Disease; Animals; Ceramides; Fingolimod Hydrochloride; Genome-Wide Association Study; Humans; Mice; Sphingolipids; Sphingomyelins

2022
Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo.
    Journal of molecular medicine (Berlin, Germany), 2023, Volume: 101, Issue:3

    Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Fingolimod Hydrochloride; Humans; Lysosomes; Mitochondria; Pancreatic Ducts; Pancreatic Neoplasms; Sphingomyelin Phosphodiesterase; Sphingomyelins

2023